WO2010119176A1 - Cell culture supplement - Google Patents
Cell culture supplement Download PDFInfo
- Publication number
- WO2010119176A1 WO2010119176A1 PCT/FI2010/050297 FI2010050297W WO2010119176A1 WO 2010119176 A1 WO2010119176 A1 WO 2010119176A1 FI 2010050297 W FI2010050297 W FI 2010050297W WO 2010119176 A1 WO2010119176 A1 WO 2010119176A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- medium
- cell culture
- fibroblasts
- proliferation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1323—Adult fibroblasts
Definitions
- the present invention relates to a conditioned medium for use as a cell culture supplement.
- the medium is obtainable by cultivating mesenchymal cells under conditions they form multicellular aggregates or spheroids.
- the medium so obtained may be used in a method for promoting proliferation of cells, preferably human fibroblasts.
- HGF hepatocyte growth factor/scatter factor
- the cell culture supplement according to this invention is a medium obtainable by cultivating mesenchymal cells under conditions that induce the cells to adhere to each other to form multicellular spheroids. The multicellular spheroids as formed are then incubated under conditions mesenchymal cells secrete growth factors to the culture medium. The medium will be ready for use after the cells have been separated therefrom.
- the medium so obtained comprises various growth factors, e.g. HGF (hepatocyte growth factor), FGF7 (keratinocyte growth factor) and amphiregulin/epiregulin.
- HGF hepatocyte growth factor
- FGF7 keratinocyte growth factor
- amphiregulin/epiregulin As can be seen from Figure 1, the medium according to the invention contains much more amphiregulin than a medium from the same cells grown as a monolayer.
- the receptors in the target cells e.g. keratinocytes and fibroblasts
- c-Met for HGF FGFR2 for FGF7
- EGFR amphiregulin/epiregulin.
- the medium of the invention was named as "Xenera”.
- Xenera sup- ports the proliferation, growth and motility of cells in a culture. It is therefore applicable to, for example, stem cell market and tissue engineering.
- the appended Figure 3 shows that Xenera stimulates proliferation of CRL fibroblasts. From Figure 4 it can be seen that even after freezing and thawing Xenera retains its stimulating effect.
- Xenera can also be used to promote isolation of primary cultures of, for instance, hepatocytes and me- lanocytes, which are difficult to cultivate.
- the primary object of the present invention is thus use of a conditioned medium, which comprises factors secreted by mesenchymal cells when cultured under conditions in which said cells form multicellular spheroids, as a cell culture supplement.
- a conditioned medium which comprises factors secreted by mesenchymal cells when cultured under conditions in which said cells form multicellular spheroids, as a cell culture supplement.
- the mesen- chymal cells are skin fibroblasts.
- Another object of the invention is use of said conditioned medium for promoting isolation of primary cultures of hepatocytes or melanocytes, which are difficult to cultivate.
- a further object of the invention is a method for promoting proliferation of cells, comprising culturing said cells in a growth medium supplemented with a conditioned medium comprising factors secreted by mesenchymal cells when cultured under conditions in which said cells form multicellular spheroids.
- the cells whose proliferation can be pro- mo ted are, for instance, keratinocytes or fibroblasts.
- the cells are human fibroblasts.
- a still further object of the invention is an improved cell culture medium for stimulating proliferation of cells, wherein the improvement comprises addition to the cell culture medium of an effective amount of a conditioned medium comprising factors secreted by mesenchymal cells when cultured under conditions in which said cells form multicellular spheroids.
- the conditioned medium of the present invention is prepared by growing mesenchymal cells, preferably fibroblasts in such cell culture conditions in which the cells form multicellular spheroids.
- a serum-free, non- supplemented cell culture medium is used.
- Suitable media are, e.g. DMEM (Dulbecco's Modified Eagle Medium), MEM (Minimum Essential Medium), ⁇ -MEM, F12 (F12 Nutrient Mixture), DMEM/F12, RMPI 1640, Kera- tinocyte defined medium (Gibco) and Endothelial cell growth medium (Lonza).
- Incubation is preferably carried out at 37 0 C in a humidified 5% CO 2 atmosphere for 3 to 5 days, and the conditioned medium so formed is harvested.
- Figure 2 Figure showing the target for Xenera comprising HGF (hepatocyte growth fac- tor), FGF7 (keratinocyte growth factor) and amphiregulin/epiregulin.
- HGF hepatocyte growth fac- tor
- FGF7 keratinocyte growth factor
- amphiregulin/epiregulin amphiregulin/epiregulin.
- Multicellular spheroids were formed on U-bottomed 96-well plates (Costar, Cambridge, MA). The plates were treated with low-electroendosmotic agarose (Bio Whittaker, Rock- land, ME) prepared in sterile water to form a thin film of non-adhesive surface. CRL-2088 fibroblasts were seeded into individual wells (15000 cells per spheroid) in 80 ⁇ l of serum free DMEM. Incubation was carried out at 37 0 C in a humidified atmosphere containing 5% CO 2 . As a control, same amount of BMSCs (Bone Marrow Stromal Cells) were di- rectly grown as a monolayer culture in a similar medium. The conditioned medium from the spheroids, as well as the monolayer medium, were collected after 5 days of incubation.
- BMSCs Breast Cells
- Kankuri E Babusikova O, Hlubinova K, Salmenpera P, Boccaccio C, Lubitz W, Harjula A, Bizik J. Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells.
- J Cancer 2008; 122: 1243-52 Kankuri E, Babusikova O, Hlubinova K, Salmenpera P, Boccaccio C, Lubitz W, Harjula A, Bizik J. Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells. Int J Cancer 2008; 122: 1243-52
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a conditioned medium for use as a cell culture supplement. The medium is obtainable by cultivating mesenchymal cells under conditions they form multicellular spheroids. The medium so obtained may be used in a method for promoting proliferation, growth and/or motility of cells, preferably human fibroblasts.
Description
Cell culture supplement
The present invention relates to a conditioned medium for use as a cell culture supplement. The medium is obtainable by cultivating mesenchymal cells under conditions they form multicellular aggregates or spheroids. The medium so obtained may be used in a method for promoting proliferation of cells, preferably human fibroblasts.
Many media for growing cells in culture are described in the literature or are commercially available. Deriving an optimal medium for specific cell culture needs can lead to improve- ments in cell growth including increased growth rates, growth to high cell densities, controlling the stage and amount of cell differentiation, increasing protein secretion or increased phenotypic and genetic stability. However, there is a constant need for effective cell culture additives or supplements for cell culturing media.
Mesenchymal-epithelial interactions in the skin between fibroblasts and epithelial kerati- nocytes present a complex interplay consisting of various cytokines and growth factors guiding cell proliferation, migration as well as differentiation. As seen with Rheinwald and Greens method of cultivating keratinocytes on a feeder layer, mesenchymal paracrine signals, such as growth factors and cytokines, remain essential for keratinocyte proliferation and survival (Werner et al., 2007). One versatile dermis derived growth factor implicated in tissue regeneration and wound healing is hepatocyte growth factor/scatter factor (HGF) (Conway et al., 2006). It has been linked to increased migration and proliferation of epithelial cells and its ligand-specific receptor c-Met is expressed in keratinocytes (Chmieloviec et al., 2007).
We previously showed that mesenchymal cell-cell activation in so-called nemosis produces massive amounts of HGF (Bizik et al., 2004), and that stimulation of keratinocytes by nemosis-derived factors enhances their migration utilizing the HGF/c-Met/PI3K pathway (Peura et al., 2009). Nemosis is a novel biological programmed cell response to high- density cell-cell contacts, and can be effectively activated in dermal fibroblasts (Kankuri et al., 2005; Kankuri et al., 2008).
The cell culture supplement according to this invention is a medium obtainable by cultivating mesenchymal cells under conditions that induce the cells to adhere to each other to form multicellular spheroids. The multicellular spheroids as formed are then incubated under conditions mesenchymal cells secrete growth factors to the culture medium. The medium will be ready for use after the cells have been separated therefrom.
The medium so obtained comprises various growth factors, e.g. HGF (hepatocyte growth factor), FGF7 (keratinocyte growth factor) and amphiregulin/epiregulin. As can be seen from Figure 1, the medium according to the invention contains much more amphiregulin than a medium from the same cells grown as a monolayer. The receptors in the target cells (e.g. keratinocytes and fibroblasts) are c-Met for HGF, FGFR2 for FGF7 and EGFR for amphiregulin/epiregulin. These receptors are illustrated in Figure 2.
The medium of the invention was named as "Xenera". We have shown that Xenera sup- ports the proliferation, growth and motility of cells in a culture. It is therefore applicable to, for example, stem cell market and tissue engineering. For instance, the appended Figure 3 shows that Xenera stimulates proliferation of CRL fibroblasts. From Figure 4 it can be seen that even after freezing and thawing Xenera retains its stimulating effect. Xenera can also be used to promote isolation of primary cultures of, for instance, hepatocytes and me- lanocytes, which are difficult to cultivate.
The primary object of the present invention is thus use of a conditioned medium, which comprises factors secreted by mesenchymal cells when cultured under conditions in which said cells form multicellular spheroids, as a cell culture supplement. Preferably, the mesen- chymal cells are skin fibroblasts.
Another object of the invention is use of said conditioned medium for promoting isolation of primary cultures of hepatocytes or melanocytes, which are difficult to cultivate.
A further object of the invention is a method for promoting proliferation of cells, comprising culturing said cells in a growth medium supplemented with a conditioned medium comprising factors secreted by mesenchymal cells when cultured under conditions in which said cells form multicellular spheroids. The cells whose proliferation can be pro-
mo ted are, for instance, keratinocytes or fibroblasts. Preferably, the cells are human fibroblasts.
A still further object of the invention is an improved cell culture medium for stimulating proliferation of cells, wherein the improvement comprises addition to the cell culture medium of an effective amount of a conditioned medium comprising factors secreted by mesenchymal cells when cultured under conditions in which said cells form multicellular spheroids.
The conditioned medium of the present invention is prepared by growing mesenchymal cells, preferably fibroblasts in such cell culture conditions in which the cells form multicellular spheroids. Preferably, a serum-free, non- supplemented cell culture medium is used. Suitable media are, e.g. DMEM (Dulbecco's Modified Eagle Medium), MEM (Minimum Essential Medium), α-MEM, F12 (F12 Nutrient Mixture), DMEM/F12, RMPI 1640, Kera- tinocyte defined medium (Gibco) and Endothelial cell growth medium (Lonza). Incubation is preferably carried out at 37 0C in a humidified 5% CO2 atmosphere for 3 to 5 days, and the conditioned medium so formed is harvested.
Brief Description of Drawings
Figure 1. The amount of amphiregulin in the conditioned medium of the invention ("Xene- ra") and the same in a "monolayer conditioned medium".
Figure 2. Figure showing the target for Xenera comprising HGF (hepatocyte growth fac- tor), FGF7 (keratinocyte growth factor) and amphiregulin/epiregulin.
Figure 3. Proliferation curves
Autostimulation of CRL fibroblasts growth by Xenera; - ■ - Xenera, - ♦ - control Y-axis shows the number of cells (103)
Figure 4. Proliferation curves
Activity of freeze-thawed Xenera on autostimulation of fibroblasts. Y-axis as in Figure 3.
Experimental
Production of conditioned medium (Xenera)
Multicellular spheroids were formed on U-bottomed 96-well plates (Costar, Cambridge, MA). The plates were treated with low-electroendosmotic agarose (Bio Whittaker, Rock- land, ME) prepared in sterile water to form a thin film of non-adhesive surface. CRL-2088 fibroblasts were seeded into individual wells (15000 cells per spheroid) in 80μl of serum free DMEM. Incubation was carried out at 37 0C in a humidified atmosphere containing 5% CO2. As a control, same amount of BMSCs (Bone Marrow Stromal Cells) were di- rectly grown as a monolayer culture in a similar medium. The conditioned medium from the spheroids, as well as the monolayer medium, were collected after 5 days of incubation.
The entire contents of all the references cited herein are hereby incorporated by reference.
References
Bizik J, Kankuri E, Ristimaki A, Taϊeb A, Vapaatalo H, Lubitz W, Vaheri A. Cell-cell contacts trigger programmed necrosis and cyclooxygenase-2 expression. Cell Death Differ 2004; 11: 183-95
Chmielowiec J, Borowiak M, Morkel M, Stradal T, Munz B, Werner S, Wehland J, Birchmeier C, Birchmeier W. c-Met is essential for wound healing in the skin. / Cell Biol 2007; 177: 151-62
Conway K, Price C, Harding K, Jiang W. The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing. Wound Repair Re- gen 2006; 14: 2-10 Kankuri E, Cholujova D, Comajova M, Vaheri A, Bizik J. Induction of Hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res 2005; 65: 9914-22
Kankuri E, Babusikova O, Hlubinova K, Salmenpera P, Boccaccio C, Lubitz W, Harjula A, Bizik J. Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells. Int J Cancer 2008; 122: 1243-52
Peura M, Bizik J, Salmenpera P, Noro A, Korhonen M, Patila T, Vento A, Vaheri A, Alita- Io R, Vuola J, Harjula A, Kankuri E. Bone marrow mesenchymal stem cells undergo ne- mosis and induce keratinocyte wound healing utilizing the HGF/c-Met/PI3K pathway. Wound Repair Re gen. 2009 JuI- Aug; 17(4): 569-77.
Werner S, Krieg T, Smola H. Keratinocyte-Fibroblast Interactions in Wound Healing. / Invest Dermatol 2007; 127: 998-1008
Claims
1. Use of a conditioned medium, which comprises factors secreted by mesenchymal cells when cultured under conditions in which said cells form multicellular spheroids, as a cell culture supplement.
2. Use according to claim 1, wherein the mesenchymal cells are human skin fibroblasts.
3. Use according to claim 1 for promoting proliferation, growth and/or motility of the cells in a culture.
4. Use according to claim 1 for promoting isolation of primary cultures of hepatocytes or melanocytes.
5. A method for promoting proliferation of human fibroblasts, comprising culturing said fibroblasts in a growth medium supplemented with a conditioned medium comprising factors secreted by mesenchymal cells when cultured under conditions in which said cells form multicellular spheroids.
6. An improved cell culture medium for stimulating proliferation of cells, wherein the improvement comprises addition to the cell culture medium of an effective amount of a conditioned medium comprising factors secreted by mesenchymal cells when cultured under conditions in which said cells form multicellular spheroids.
7. The improved cell culture medium according to claim 6 for stimulating proliferation of keratinocytes or fibroblasts.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20095409A FI20095409A0 (en) | 2009-04-14 | 2009-04-14 | Soluviljelysupplementti |
| FI20095409 | 2009-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2010119176A1 true WO2010119176A1 (en) | 2010-10-21 |
Family
ID=40590290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/FI2010/050297 Ceased WO2010119176A1 (en) | 2009-04-14 | 2010-04-13 | Cell culture supplement |
Country Status (2)
| Country | Link |
|---|---|
| FI (1) | FI20095409A0 (en) |
| WO (1) | WO2010119176A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015001124A1 (en) | 2013-07-05 | 2015-01-08 | Université Catholique de Louvain | Conditioned medium from human adult liver stem cells and its use in the treatment of liver disorders |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5496800A (en) * | 1988-09-02 | 1996-03-05 | Baylor College Of Medicine | Growth inhibitory factor from urogenital sinus |
| WO2005042703A2 (en) * | 2003-10-22 | 2005-05-12 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Placental stem cells and uses thereof |
| WO2007113387A1 (en) * | 2006-03-31 | 2007-10-11 | Jozef Bizik | Method and device for treating or selecting cells |
-
2009
- 2009-04-14 FI FI20095409A patent/FI20095409A0/en not_active Application Discontinuation
-
2010
- 2010-04-13 WO PCT/FI2010/050297 patent/WO2010119176A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5496800A (en) * | 1988-09-02 | 1996-03-05 | Baylor College Of Medicine | Growth inhibitory factor from urogenital sinus |
| WO2005042703A2 (en) * | 2003-10-22 | 2005-05-12 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Placental stem cells and uses thereof |
| WO2007113387A1 (en) * | 2006-03-31 | 2007-10-11 | Jozef Bizik | Method and device for treating or selecting cells |
Non-Patent Citations (6)
| Title |
|---|
| BERASAIN C. ET AL: "Amphiregulin: an early trigger of liver regeneration in mice", GASTROENTEROLOGY, vol. 128, 2005, pages 424 - 432, XP005313376 * |
| CELL TRANSPLANTATION, vol. 11, no. 4, 2002, pages 385 - 395 * |
| DATABASE MEDLINE [online] HAMOEN K.E. ET AL: "Transient hyperproliferation of a transgenic human epidermis expressing hepatocyte growth factor", XP003027111, Database accession no. 12162379 * |
| ITOH T. ET AL: "Keratinocyte Growth Factor as a Mitogen for Primary Culture of Rat Hepatocytes", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 192, no. 3, 1993, pages 1011 - 1015, XP024767638 * |
| KANKURI E. ET AL: "Induction of Hepatocyte Growth Factor/Scatter Factor by Fibroblast Clustering Directly Promotes Tumor Cell Invasiveness", CANCER RESEARCH, vol. 65, no. 21, November 2005 (2005-11-01), pages 9914 - 9922, XP003019489 * |
| KOMURASAKI T. ET AL: "Mechanism of Growth Promoting Activity of Epiregulin in Primary Cultures of Rat Hepatocytes", GROWTH FACTORS, vol. 20, no. 2, 2002, pages 61 - 69, XP008077489 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015001124A1 (en) | 2013-07-05 | 2015-01-08 | Université Catholique de Louvain | Conditioned medium from human adult liver stem cells and its use in the treatment of liver disorders |
| US10874699B2 (en) | 2013-07-05 | 2020-12-29 | Université Catholique de Louvain | Conditioned medium from human adult liver stem cells and its use in the treatment of liver disorders |
| US11793837B2 (en) | 2013-07-05 | 2023-10-24 | Université Catholique de Louvain | Conditioned medium from human adult liver stem cells and its use in the treatment of liver disorders |
Also Published As
| Publication number | Publication date |
|---|---|
| FI20095409A0 (en) | 2009-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI334443B (en) | Method of single cell culture of undifferentiated human embryonic stem cells | |
| CN114480273A (en) | Culture medium for obtaining mesenchymal stem cells and exosomes thereof and preparation method thereof | |
| CN104726406B (en) | It is a kind of to induce the method that dental pulp Derived from Mesenchymal Stem Cells is nerve cell | |
| KR100832592B1 (en) | Coculture of Stem Cells and Feeder Cells Using Polymer Membranes | |
| Bullock et al. | Use of human fibroblasts in the development of a xenobiotic-free culture and delivery system for human keratinocytes | |
| RU2012110181A (en) | METHOD FOR OBTAINING AN ARTIFICIAL BODY | |
| KR102679956B1 (en) | Method of culturing muscle cells for producing cattle cultured meat | |
| CN103898056A (en) | Cell culture medium and application thereof in culturing primary human tumor cells | |
| CA2470853A1 (en) | Human cell culture medium and culture method | |
| CN104774808A (en) | Method for inducible differentiation of umbilical cord mesenchymal stem cells into gamma-aminobutyric acid-ergic neuron | |
| Zupančič et al. | Co‐culturing porcine normal urothelial cells, urinary bladder fibroblasts and smooth muscle cells for tissue engineering research | |
| KR20110097064A (en) | Serum-free stem cell culture composition, composition for regenerating tissue containing same and tissue regeneration method using same | |
| CN104789531B (en) | A kind of method that umbilical cord mesenchymal stem cells are induced differentiation into dopaminergic neuron | |
| KR101984227B1 (en) | The method for isolation of stem cells from bone marrow using subfractionation culturing method and proliferation thereof | |
| CN104988111A (en) | Inducing liquid for converting UC-MSC into islet cells and application thereof | |
| CN113667632B (en) | Cell culture medium additive, cell culture medium and method for in-vitro cell expansion | |
| CN119391631A (en) | Umbilical cord mesenchymal stem cell adipogenic differentiation medium and culture method | |
| KR20180092523A (en) | Serum-free medium additive composition and method for inducing chondrogenesis of mesenchymal stem cells | |
| CN107287150B (en) | Construction method of 3D (three-dimensional) epidermis model | |
| KR101768632B1 (en) | Method of separating cultured epithelial sheet by calcium pulse | |
| CN111304163A (en) | Large-scale culture method of umbilical cord mesenchymal stem cells | |
| CN106282089B (en) | A kind of efficient amplification cultivating system of non-human primate endothelial progenitor cell | |
| KR102147780B1 (en) | Culture medium composition for promoting the proliferation of stem cell comprising FGF-17 as an effective ingredient and method of culturing stem cells using the same | |
| CN104774807A (en) | Method for inductively differentiating umbilical cord mesenchymal stem cells into oligodendroglia cells | |
| KR20190130394A (en) | A composition for stimulating differentiation of stem cell comprising multi-layer graphene film and culture broth of progenitor cell |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10764148 Country of ref document: EP Kind code of ref document: A1 |
|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 10764148 Country of ref document: EP Kind code of ref document: A1 |